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Silicosis is characterized by chronic lung inflammation and fibrosis, which are 
extremely harmful to human health. The pathogenesis of silicosis involves uncontrolled 
immune processes. Evidence supports that regulatory B cells (Bregs) produce 
negative regulatory cytokines, such as IL-10, which can negatively regulate immune 
responses in inflammation and autoimmune diseases. Our previous study found 
that IL-10-producing B cells were involved in the development of silica-induced lung 
inflammation and fibrosis of mice. However, little is known about the role of Bregs 
in silicosis patients (SP). In this study, we found that serum concentrations of IL-10 were 
significantly increased in SP by using protein array screening. We further determined 
that the frequency of IL-10-producing CD1dhiCD5+ Bregs, not IL-10-producing non-B 
lymphocytes, was significantly higher in SP compared to subjects under surveillance 
(SS) and healthy workers (HW) by flow cytometry. We also found that regulatory T cells 
(Tregs) and Th2 cytokines (IL-4, IL-5, and IL-13) were significantly increased in SP. Th1 
cytokines (IFN-γ, IL-2, and IL-12) and inflammatory cytokines (IL-1β, IL-6, and TNF-α) 
were not significantly different between SP, SS, and HW. Our study indicated that IL-10-
producing CD1dhiCD5+ Bregs might maintain Tregs and regulate Th1/Th2 polarization 
in SP, suggesting that IL-10-producing Bregs may play a critical role in modulating 
immune homeostasis in SP.
Keywords: il-10, regulatory B cells, regulatory T cells, Th1/Th2 polarization, immune homeostasis, silicosis 
patients
inTrODUcTiOn
Silicosis is a potentially fatal, but preventable, occupational lung disease caused by inhaling 
respirable crystalline silica (1). It is characterized by chronic lung inflammation and irreversible 
fibrosis (2). Progressive fibrosis leads to disability and mortality in patients, which results 
in a heavy burden to society. In China, there were 11,471 cases of silicosis reported in 
2014, accounting for 42.69% of 26,873 new pneumoconiosis cases (Ministry of Health of 
the People’s Republic of China, 2015). Silicosis is reported to be a special concern in young 
2Chen et al. Bregs Modulate Immune Homeostasis
Frontiers in Immunology | www.frontiersin.org February 2017 | Volume 8 | Article 110
adults (aged 15–44 years) (3). Silicosis has become the most 
serious occupational disease in both developed and developing 
countries, yet little is known about the crucial cellular and 
molecular mechanisms that initiate and propagate the process 
of silicosis.
Previous evidence has shown that both innate and adap-
tive immune responses play a key role in the pathogenesis of 
silicosis (4, 5). Alveolar macrophages, the first defense against 
foreign substances, ingest inhaled silica and become activated to 
release a host of mediators, such as cytokines and chemokines, 
which initiate the influx of inflammatory cells and activation 
of immune cells (6, 7). The complex network of interactions 
between mediators and cells results in the onset of lung injury, 
inflammation, and potentially fibrosis. The inflammation media-
tors are involved in the causation of silicosis. Chemokines that 
primarily attract monocytes and macrophages induce inflamma-
tion mediators such as IL-1β, IL-6, and TNF-α, which initiate the 
activation of T and B immune cells and stimulate T-lymphocyte 
type switching (8, 9).
Previous studies have demonstrated that Th1 and Th2 cells 
participate in the pathogenesis of silicosis (10, 11). Regulatory 
T cells (Tregs) play a role of the maintenance of immune 
homeostasis, which limits inflammation and modulates Th1/
Th2 balance in silica-induced lung fibrosis (12). However, other 
regulatory subsets in  silicosis have not been investigated in 
detail, and the mechanism of immune homeostasis modulation 
needs further exploration. Recent studies have demonstrated 
that another regulatory lymphocyte, specific B cell subsets, so-
called regulatory B cells (Bregs), are potent immune response 
regulators and play important roles in regulating immune 
homeostasis (13, 14). A number of Breg subsets have been 
reported, of which the IL-10-producing B cell (B10) subset 
is among the best characterized (15, 16). Subsequent studies 
have shown that CD1dhighCD5+ B cells were associated with the 
suppression of inflammation and autoimmune disease through 
IL-10 secretion (17, 18). B10 was also found to participate in 
regulating Th immune response by affecting the secretion of 
inflammatory cytokines such as TNF-α (19–21). In addition, 
B10 influences the proliferation of Tregs (22). Recent findings 
have shown that frequencies of peripheral Bregs increased in 
patients with lung cancer and B10s were significantly elevated 
in non-small cell lung carcinoma patients (23, 24). CD1d+CD5+ 
B cell numbers were increased in patients with tuberculosis 
(25). Our previous study found that B10 was involved in the 
development of silica-induced lung inflammation and fibrosis 
of mice (26). However, little is known about the role of similar 
or equivalent regulatory B lymphocyte populations in  silicosis 
patients (SP).
A protein microarray assay and Bio-Plex assay were used in 
the present study to find that the level of IL-10 was increased 
in the serum of SP. To explore whether the increased IL-10 
was produced by B and/or T cell populations and to determine 
the role of Bregs in SP, we investigated peripheral B10 and 
CD19+ IL-10+CD1dhiCD5+ B cell subsets and Tregs and also 
determined the level of chemokines, inflammation mediators, 
and Th1 and Th2 cytokines in SP, subjects under surveillance 
(SS), and healthy workers (HW) that had prior exposure to 
silica dust. Our results may provide new insights into the role 
of Bregs in SP.
MaTerials anD MeThODs
study Design
The study, conducted from May 2015 to March 2016, included 
57 individuals. Nineteen first phase male SP were recruited 
from Shenyang No. 9 Hospital. Nineteen SS and nineteen 
HW with exposure to silica dust from Northern Heavy 
Industries Group Co., Ltd., matched by sex, age, year of 
exposure to silica dust, and ethnicity with SP were enrolled 
in this study. Criteria were based on the national diagnostic 
criteria of pneumoconiosis (GBZ70-2009). SS were workers 
with exposure to silica, who had no certain shadow changes 
visible in the chest X-ray films by health examination, and 
who needed periodic follow-ups within specified periods of 
time. The diagnosis of silicosis was based upon patient his-
tory of exposure to silica and available chest X-rays and was 
made by five qualified experts, who served as members of the 
Shenyang Municipal Pneumoconiosis Diagnosis Committee. 
Patients with chronic inflammatory diseases, respiratory 
infectious diseases, tuberculosis, asthma, diabetes, or cancer 
autoimmune disease were excluded.
Pulmonary function was measured from 2015 to 2016 by 
using spirometry. The data collected included forced vital capac-
ity (FVC) and forced expiratory volume in 1 s (FEV1). Personal 
information, including sex, age, exposure period, and smoking 
status were obtain via questionnaire.
This study was carried out in accordance with the recom-
mendations of the Ethics Committee of the China Medical 
University with written informed consent from all subjects. 
All subjects gave written informed consent in accordance with 
the Declaration of Helsinki. The protocol (CMU2100012006) 
was approved by the Ethics Committee of the China Medical 
University.
Blood sample
Five milliliters of venous blood samples were collected into no 
additive vacutainer tubes. Serum was obtained after centrifuga-
tion and stored at −80°C for protein microarray analysis and the 
Bio-Plex assay.
Also, 6  ml venous blood samples were collected into vacu-
tainer tubes containing EDTA. Peripheral blood mononuclear 
cells (PBMCs) were immediately isolated by Ficoll density gradi-
ent centrifugation (TBD sciences, China) for Flow cytometric 
analysis.
Protein Microarray analysis
RayBiotech Human Cytokine Antibody Array 440 (RayBiotech, 
Inc., Cat# QAH-CAA-440) was used to profile the variation of 
proteins in serum. The samples were detected by the Shanghai 
XY Biotech Company. The experimental procedure was car-
ried out in accordance with the manufacturer’s instructions. 
Briefly, pre-coated antibody array membranes were incubated 
with coating buffer for 30  min. After that, the blocking buffer 
was decanted and replaced with sample dilutions. Membranes 
TaBle 1 | characteristics of study participants.
hW (male, 
n = 19)
ss (male, 
n = 19)
sP (male, 
n = 19)
p-Value
Age (years) 52.26 ± 0.82 52.32 ± 0.69 53.26 ± 1.00 0.65a
Exposure period 
(years)
30.21 ± 0.83 30.00 ± 0.92 28.05 ± 0.93 0.18a
%FVC predicted 90.81 ± 2.50 91.28 ± 3.46 67.41 ± 6.82#,* 0.001a
%FEV1 predicted 90.79 ± 3.15 95.45 ± 3.83 72.23 ± 6.20#,* 0.002a
%FEV1/FVC radio 84.90 ± 1.55 88.88 ± 1.49 71.91 ± 3.21#,* <0.001a
Smoking, N (%) 0.94b
Never 7 (36.8) 8 (42.1) 8 (42.1)
Past 1 (5.3) 1 (5.3) 2 (10.5)
Current 11 (57.9) 10 (52.6) 9 (47.4)
HW, healthy workers with exposure to silica dust; SS, subjects under surveillance; SP, 
silicosis patients; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s.
Values are expressed as means ± SEM, #p < 0.05 compared with HW, *p < 0.05 
compared with SS.
aCalculated by one-way analysis of variance.
bCalculated by chi-square test.
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were incubated overnight at 4°C with shaking. The next day, 
the membranes were incubated with biotin-conjugated antibody 
for 2 h after washing. Mixture of biotin-conjugated antibodies 
was removed and Streptavidin-Fluor was added to each sub-
array. The incubation chambers were covered with adhesive film 
and incubated for 2  h. After washing, signals were detected 
with a GenePix 4000B system (Axon Instruments, Foster City, 
CA, USA). GenePix Pro 6.0 software (Axon Instruments) was 
used for densitometric analysis of the spots. These values were 
normalized to the ratio of positive control values for each sample. 
Afterward, the total normalized fluorescence values of replicate 
spots were averaged and expressed as fold increase over the 
control samples.
Bio-Plex assay
The levels of 27 cytokines in serum were measured by the 
Bio-Plex Pro™ human cytokine 27-plex assay (Bio-Rad 
Laboratories, Hercules, CA, USA; Cat# M500KCAF0Y). This 
multiplex assay detects: FGF basic, Eotaxin, G-CSF, GM-CSF, 
IFN-γ, IL-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, 
IL-10, IL-12 (p70), IL-13, IL-15, IL-17, inducible protein-10 
(IP-10), monocyte chemoattractant protein-1 (MCP-1), mac-
rophage inflammatory protein-1 (MIP-1)α, MIP-1β, PDGF-BB, 
RANTES, TNF-α, and VEGF. The experimental procedure 
was carried out according to the manufacturer’s instructions. 
Briefly, beads coated with capture antibodies were incubated 
with premixed standards or sample supernatants for 30  min. 
Following incubation, premixed detection antibodies were 
added and incubated as before. After washing, streptavidin-
PE was added and incubated for 10  min. After washing, the 
beads were resuspended in Bio-Plex cytokine assay buffer, and 
results were read on the Bio-Plex 200 system using Low PMT 
setting. Data were analyzed with Bio-Plex Manager™ software 
version 2.0.
cell Preparation and Flow 
cytometry analysis
Peripheral blood mononuclear cells were isolated from blood 
samples by Ficoll density gradient centrifugation. After washing 
and addition of RPMI1640 medium, PBMCs were stimulated 
with Leukocyte Activation Cocktail (BD Pharmingen, San Jose, 
CA, USA) for 5  h, followed by blocking with Human BD Fc 
Block™ (BD Pharmingen) for 10  min at room temperature. 
PE-Cy7-conjugated CD4 (BD Pharmingen) and PerCP-Cy5.5-
conjugated CD19 (BD Pharmingen) antibodies were used for 
cell surface staining. Cells were fixed and permeabilized using a 
fixation/permeabilization kit (eBioscience, San Diego, CA, USA) 
or BD Cytofix/Cytoperm™ Fixation/Permeabilization Solution 
kit (BD Pharmingen) according to the manufacturer’s instruc-
tions. The cells were then stained at 4°C with APC-conjugated 
anti-Foxp3 (BD Pharmingen), APC-conjugated anti-IL-10 (BD 
Pharmingen), FITC-conjugated anti-CD5 (BD Pharmingen), 
and PE-conjugated anti-CD1d (BD Pharmingen). After washing, 
stained cells were resuspended in 1% paraformaldehyde-PBS. 
Analysis of cell marker expression was performed using a 
FACSCanto II system (BD, Franklin Lakes, NJ, USA). Dead 
cells were gated out depending on forward scattering and side 
scattering. Cells were analyzed with FlowJo X software (Tree 
Star, OR, USA).
statistical analyses
Data were analyzed for statistical significance using SPSS 19.0 
software (SPSS Inc., Chicago, IL, USA). Means between two 
groups were analyzed by Student’s t-test. The differences between 
values were evaluated through a one-way analysis of variance 
followed by pair-wise comparison with the Student–Newman–
Keuls test. The chi-square test was used to compare categorical 
variables. Also, p < 0.05 was considered statistically significant. 
All values are means ± SEM.
resUlTs
study subjects
The general characteristics of the study subjects are shown in 
Table  1. No difference in general characteristics, including 
median age, exposure period, and smoking status, were found 
between three groups. Pulmonary function (%FVC predicted, 
%FEV1 predicted, %FEV1/FVC radio) in SP was significantly 
decreased compared to SS and HW.
Multiple cytokines altered in serum of sP
To profile the cytokines in the peripheral blood from patients 
with silicosis, a blinded screening using serum of SP, SS, and 
HW by protein microarray analysis was performed. As shown 
in the heat maps, 46 kinds of cytokines were different between 
SP and SS, and 18 kinds of cytokines were different between 
SP and HW. Fifty-six kinds of cytokines were different among 
HW, SS, and SP groups (data shown in Tables S1–S3 in 
Supplementary Material, respectively). Among those cytokines, 
there was a marked increase of IFN-γ, IL-7, TNF-α, IL-10, 
IL-13, IL-6, IL-5, and IL-8 in SP (n  =  5) compared to SS 
(n  =  5) (Figure  1A). There was also a marked increase of 
FigUre 1 | a profile of cytokines in serum of silicosis patients (sP) was detected by protein microarray. (a) Heat map analysis between SP and SS. 
Image showed a marked increase of IFN-γ, IL-7, TNF-α, IL-10, IL-13, IL-6, IL-5, and IL-8 in SP (n = 5) compared to SS (n = 5). Red represents upregulated protein 
expression, and green represents downregulated protein expression. (B) Heat map analysis between SP and workers exposed to silica dust. Image showed a 
marked increase of GM-CSF, IL-10, and IL-6 in SP (n = 5) compared to healthy workers (HW) (n = 5). Red represents upregulated protein expression, and green 
represents downregulated protein expression.
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GM-CSF, IL-10, and IL-6 in SP (n  =  5) compared to HW 
(n =  5) (Figure  1B). The levels of IL-10 showed significance 
difference between SP and SS (p = 0.00001). The levels of IL-10 
were significantly different between SP and HW (p = 0.00082). 
These results suggested that IL-10 might play a critical role in 
the pathogenesis of silicosis.
FigUre 2 | level of il-10 in serum, il-10-producing B cell (B10), and il-10+cD1dhighcD5+ B cell subsets in the peripheral blood were assayed in all 
participants. (a) The level of IL-10 in serum was assayed by the Bio-Plex assay. (B,e,F) Percentages of CD19+IL-10+ B cells and CD19-IL-10+ cells in the 
peripheral blood were assayed by flow cytometry. (c,g) Percentage of IL-10+CD1dhighCD5+ B cells in the peripheral blood was assayed by flow cytometry. (D) The 
overlay graph of CD1d unstained and CD1d stained histograms [n = 19 per group, #p < 0.05 compared with healthy workers (HW); *p < 0.05 compared with SS]. 
Error bars indicate mean ± SEM.
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serum level of il-10 and il-10-Producing 
cD1dhighcD5+ Bregs Were increased in sP
The sample size was enlarged (n = 19), and the Bio-Plex array 
was used to further confirm the variation of serum IL-10 
in SP. The Bio-Plex suspension array system permitted the 
simultaneous measurement of 27 human cytokines, including 
interleukins, chemokines, colony-stimulating factors, growth 
factors, interferon, and tumor necrosis factor (data of 27 
cytokines shown in Table S4 in Supplementary Material). 
The results showed that the serum concentrations of IL-10 
were significantly increased in SP compared to SS and HW 
(p =  0.03, p =  0.017) (Figure  2A). To explore the possibil-
ity that the increased IL-10 was produced by B cell and/
or T cell populations, peripheral B10s and IL-10-producing 
non-B lymphocytes were investigated from all participants. 
The percentage of CD19+IL-10+ B cells was observed to 
significantly increase in SP (2.02 ±  0.23%) compared to the 
SS group (1.46 ±  0.14%) and the HW group (1.21 ±  0.11%) 
(Figures 2B,F). However, there were no obvious differences in 
the percentage of CD19-IL-10+ lymphocytes between the three 
groups (Figures  2B,E). These data suggested that increased 
serum IL-10 in SP might contribute to B10s, but not IL-10-
producing non-B lymphocytes.
Emerging evidence indicates that CD1dhiCD5+ B cells 
are responsible for most of the IL-10 production by B cells 
(17).  We  investigated peripheral IL-10-producing CD1dhiCD5+ 
B  cells in all participants. Our flow cytometry results showed 
that a proportion of cells highly expressed CD1d in CD19+ 
B cells (Figure 2D). The percentage of IL-10+CD1dhiCD5+ B cells 
significantly increased in SP (0.89 ± 0.18%) compared to the SS 
(0.39 ± 0.06%) and HW (0.24 ± 0.05%) groups (Figures 2C,G). 
These data suggested that IL-10+CD1dhiCD5+ B cells might play 
a critical role in the pathogenesis of silicosis.
serum levels of chemokines Were 
increased in ss
Of the 27 cytokines detected by the Bio-Plex assay, some 
chemokines tended to increase in the early stages of silicosis. 
FigUre 3 | chemokines in serum were detected in all participants. (a) Level of monocyte chemoattractant protein-1 (MCP-1) in serum was assayed by the 
Bio-Plex assay. (B) The level of inducible protein-10 (IP-10) in serum was assayed by the Bio-Plex assay. (c) The level of macrophage inflammatory protein-1 
(MIP-1)α in serum was assayed by the Bio-Plex assay. (D) The level of MIP-1β in serum was assayed by the Bio-Plex assay [n = 19 per group, #p < 0.05 compared 
with healthy workers (HW); *p < 0.05 compared with subjects under surveillance (SS)]. Error bars indicate mean ± SEM.
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Compared with HW, the serum concentration of MCP-1 in 
SS and  SP was significantly increased (p =  0.008, p =  0.002) 
(Figure 3A). In addition, the serum concentration of interferon 
gamma-IP-10 was increased in SS and SP compared to HW 
(Figure 3B). The serum concentrations of MIP-1α and MIP-1β 
were increased in SS compared to HW and SP (Figures 3C,D), but 
these differences were not statistically significant. These results 
suggested that some chemokines might initially be secreted by 
activated macrophages.
Tregs, not inflammatory cytokines, Were 
increased in sP
To investigate whether Bregs could affect the production of 
inflammatory cytokines and maintain Tregs in SP, inflamma-
tory cytokines were detected using the Bio-Plex assay, and 
Tregs in PBMCs were analyzed by flow cytometry. The results 
showed no significant difference in the serum concentrations 
of inflammatory cytokines IL-1β, IL-6, and TNF-α between 
the three groups (Figures  4A–C). The percentage of CD4+ 
T cells expressing Foxp3, which were identified as Tregs, 
increased significantly in SP (5.92 ±  0.36%) compared with 
that of SS (3.88 ± 0.38%) and HW (3.91 ± 0.33%) (p < 0.001, 
p < 0.001) (Figures 4D,E). These results suggested that Bregs 
might inhibit the production of inflammatory cytokines and 
maintain Tregs in SP.
Th2 cytokines, not Th1 cytokines, 
Were increased in sP
To investigate effects of Bregs on the Th1/Th2 immune response, 
the levels of Th1/Th2 cytokines were assayed in all participants. 
There was no significant difference in the levels of Th1 cytokine 
IFN-γ, IL-2, and IL-12 (p70) in serum between the SP, SS, and 
HW groups (Figures 5A–C). In contrast, the serum concentra-
tion of IL-4 was significantly increased in SP compared to SS and 
HW (p = 0.015, p = 0.039) (Figure 5D). The serum concentra-
tion of IL-5 was significantly increased in SP compared to SS 
(p = 0.012) and obviously increased compared to HW (p = 0.098) 
(Figure 5E). The serum concentration of IL-13 was significantly 
increased in SP compared to HW (p =  0.011) and obviously 
increased compared to SS (p = 0.056) (Figure 5F). These results 
suggested that Bregs might inhibit the secretion Th1 cytokines 
and promote the secretion Th2 cytokines to modulate Th1/Th2 
immune responses in SP.
DiscUssiOn
IL-10 is a pleiotropic cytokine produced by a number of leu-
kocyte populations that impacts immune regulation and tissue 
homeostasis (27, 28). B10s play an important role in maintain-
ing immune homeostasis (29). In this study, we found that the 
serum concentration of IL-10 was significantly increased in SP 
FigUre 5 | levels of Th1/Th2 cytokines were assayed in all participants. (a) The level of IFN-γ in serum was assayed by the Bio-Plex assay. (B) The level of 
IL-2 in serum was assayed by the Bio-Plex assay. (c) The level of IL-12 (p70) in serum was assayed by the Bio-Plex assay. (D) The level of IL-4 in serum was 
assayed by the Bio-Plex assay. (e) The level of IL-5 in serum was assayed by the Bio-Plex assay. (F) The level of IL-13 in serum was assayed by the Bio-Plex assay 
[n = 19 per group, #p < 0.05 compared with healthy workers (HW); *p < 0.05 compared with subjects under surveillance (SS)]. Error bars indicate mean ± SEM.
FigUre 4 | levels of inflammatory cytokines in serum and regulatory T cells (Tregs) in the peripheral blood were assayed in all participants. (a) The 
level of IL-1β in serum was assayed by the Bio-Plex assay. (B) The level of IL-6 in serum was assayed by the Bio-Plex assay. (c) The level of TNF-α in serum was 
assayed by the Bio-Plex assay. (D,e) Percentage of CD4+Foxp3+ Tregs in the peripheral blood was assayed by flow cytometry [n = 19 per group, #p < 0.05 
compared with healthy workers (HW); *p < 0.05 compared with subjects under surveillance (SS)]. Error bars indicate mean ± SEM.
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compared to SS and HW by protein microarray analysis and 
the Bio-Plex assay. We compared the frequencies of IL-10-
secreting B cells and IL-10-secreting non-B lymphocytes in all 
participants and determined that the frequency of B10s, not 
IL-10-producing non-B lymphocytes, was higher in SP than in 
SS and HW groups.
Regulatory B cells are important suppressors of inflamma-
tion and other autoimmune responses, producing the negative 
regulatory cytokines, IL-10 and TGF-β (30). IL-10 and TGF-
β-producing B cells mediate tolerance in acute allergic airway 
inflammation (31). However, IL-10 is considered the hallmark 
cytokine of Bregs. B10s were the first Bregs to be recognized and 
were termed “B10” cells (32). Emerging evidence indicates that 
CD1dhiCD5+ B cells are responsible for most IL-10 production 
by B cells (17, 33). The function of Bregs was mediated by IL-10 
and dependent on the expression of CD1d (20, 34). A Bregs’ 
FigUre 6 | schematic representation of il-10-producing cD1dhighcD5+ regulatory B cells (Bregs) in modulating immune homeostasis in silicosis patients.
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deficiency leads to increased allergic airway Inflammation (35). 
Our results showed that the percentage of IL-10+CD1dhiCD5+ 
B cells significantly increased in SP compared to SS and HW 
groups. The increase of B10s and IL-10+CD1dhiCD5+ B cells in SP 
might be the results of effective immune response to lung injury. 
IL-10+CD1dhiCD5+ B cells might play a critical role in modulat-
ing immune homeostasis of SP (Figure 6).
The pathogenesis of silicosis involves alveolar cell injury 
and activation followed by release of cytokines and recruit-
ment of cells into the areas of silica dust deposition (10, 36, 37). 
Chemokines such as MCP-1, MIP-1, and IP-10 are chemotactic 
cytokines that recruit specific groups of monocytes/macrophages 
and lymphocytes, which are involved in many chronic lung dis-
eases (38–41). MCP-1 is a potent chemotactic factor for blood 
monocytes and produced by various inflammatory cells, which 
has been considered a potential biomarker for the progress of 
coal worker’s pneumoconiosis (42). Our results showed that the 
levels of MCP-1 and IP-10, especially MCP-1, were significantly 
increased in SS and SP compared to HW. These results suggested 
that chemokines were involved in the initial stages of silicosis.
It is now widely appreciated that B cells can suppress inflam-
mation and negatively regulate immune responses, in part 
through the secretion of anti-inflammatory IL-10 (19, 26, 43). 
The production of pro-inflammatory cytokines, such as IL-1β, 
IL-6, and TNF-α, by monocytes and macrophages is suppressed 
by IL-10 (39). In our previous study, we found that the levels of 
secreted TNF-α and IL-6 proteins in BALF clearly increased in 
B10-deficiency mice injected with an anti-CD22 antibody (26). 
Our data revealed that the serum concentrations of IL-1β, IL-6, 
and TNF-α were not significantly different between the SP, SS, 
and HW groups. B10s might partly restrain inflammation of 
silicosis by downregulating the production of pro-inflammatory 
cytokines. In addition, it has recently been shown that B10s are 
crucial for the maintenance of Tregs function (44–47). It was 
reported in mice that tumor-induced B10s could convert resting 
CD4+ non-Tregs into Tregs (48). Another study showed that B10s 
promoted Tregs accumulation and function by stimulating Foxp3 
expression (49). In our previous study, insufficient B10s reduced 
the frequency of Tregs, whereas Treg depletion did not influence 
B10 accumulation in silicosis of mice. B10s might act earlier than 
Tregs during silica-induced lung inflammation and fibrosis (26). 
Our present data showed that Tregs significantly increased in SP 
compared to SS and HW. These results indicated that Bregs might 
maintain Tregs function, which is involved in suppressing inflam-
mation and regulating Th immune responses in SP (Figure 6).
Regulatory B cells have been found to have regulatory proper-
ties in inducing primary T cell proliferation and in generating 
and maintaining CD4+ effect T cells (50). It was reported that 
B cell depletion therapy was associated with changes in T cell 
repertoire and function in patients with idiopathic thrombocy-
topenic purpura (51). Our previous studies had demonstrated 
insufficient B10 could exacerbate Th1 immune response and 
elevate levels of IFN-γ in  silicosis of mice (26). Studies have 
shown B10s can influence the development of Th2 cells (52, 53). 
In the current study, the levels of Th1 cytokines IFN-γ, IL-2, and 
IL-12 (p70) in serum were found to have no significant difference 
among the three groups. The levels of Th2 cytokines IL-4, IL-5, 
and IL-13 in serum significantly increased in SP compared to 
SS and/or HW. These results suggested that increased levels of 
IL-10/IL-10-producing CD1dhiCD5+ Bregs might inhibit the 
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production of Th1 cytokines  and maintain secretion of Th2 
cytokines to regulate the Th1/Th2 balance toward a Th2 pheno-
type in SP (Figure 6).
The results of the present study show that increased level 
of inhibitory cytokine IL-10 and number of IL-10-producing 
CD1dhiCD5+ Bregs may maintain Tregs and regulate Th1/Th2 
polarization, suggesting that IL-10-producing Bregs may play a 
critical role in modulating immune homeostasis in SP. However, 
how B cells differentiate into IL-10-producing Bregs and what 
functions the cells play in  silicosis progression remain to be 
further investigated.
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